Cardiokol
Voice-based Markers for Large-scale Monitoring and Screening of Heart Rhythm Disorders
Company Overview
Snapshot
Founded in August 2017 by Alon Goren, Eli Attar, and Pini Sabach, Cardiokol operates with 1–10 employees. The company has raised $8M across two funding rounds from two investors. In November 2021, Cardiokol was selected to join Bayer's G4A program, highlighting its innovative approach in digital health.
Business overview
Cardiokol is a digital telehealth company focused on developing voice-based markers and methods for the large-scale monitoring and screening of heart rhythm disorders. The company leverages proprietary technology, implemented across various speech platforms including landlines, smartphones, smart speakers, and voice assistants, to offer low-cost, long-term, and user-friendly monitoring solutions. Cardiokol primarily serves at-risk populations, particularly older adults (65+), operating within the Health Tech & Life Sciences sector, with a focus on Digital Healthcare and Patient Remote Monitoring.
Strategic signal
In November 2021, Cardiokol was selected as one of nine digital health pioneers to join Bayer's G4A program. This participation signals strong industry validation for Cardiokol's voice-based technology in heart rhythm disorder screening and monitoring, positioning the company for potential strategic partnerships and accelerated market access within the digital health ecosystem.
Log in to access full profile ›Company Intelligence Q&A
- When was Cardiokol founded and by whom?
- Cardiokol was founded in August 2017 by Alon Goren, Eli Attar, and Pini Sabach.
- What is Cardiokol's primary focus?
- Cardiokol focuses on developing voice-based markers and methods for monitoring and screening heart rhythm disorders in large at-risk populations, particularly older adults.
- What significant program did Cardiokol join in 2021?
- In November 2021, Cardiokol joined Bayer's G4A program as one of nine digital health pioneers.
- How much capital has Cardiokol raised?
- Cardiokol has raised $8M in total funding across two rounds.
- Which investors participated in Cardiokol's funding rounds?
- Cardiokol has received funding from investors including Kamet Ventures and KYTO.